About League
League.com connects healthcare providers with consumers through a digital platform that enhances the customer experience in the healthcare sector. The platform offers personalized, omnichannel experiences by integrating various systems and utilizing machine learning to tailor interactions for each user throughout their healthcare journey. Unlike many competitors, League.com allows healthcare brands to quickly deploy new applications or embed them into existing systems, adapting to changing business needs in under six months. The company's goal is to improve patient engagement, retention, and overall healthcare experiences while reducing costs for both providers and consumers.
Toronto, CanadaHeadquarters
2014Year Founded
$166.4MTotal Funding
SERIES_CCompany Stage
AI & Machine Learning, HealthcareIndustries
201-500Employees
Benefits
Personalized benefits plan
Health, Lifestyle & Learning spending accounts
Flexible medical and dental plans
Fertility treatment support
Paid parental leave and baby bonus
Unlimited PTO
Free mental health counselling and support
Employee Stock Option Program
Exclusive access to a curated wellness marketplace
Sabbatical program
RRSP/401K accounts
High-impact onboarding
Extra-long holiday weekends
Mental health (wellness) days
Risks
Increased competition from other digital health platforms may dilute League's market share.
Rapid technological advancements require costly updates to League's platform.
Data privacy concerns could undermine consumer trust in League's platform.
Differentiation
League offers a flexible platform integrating third-party and proprietary systems.
The platform uses machine learning for hyper-personalized healthcare experiences.
League's platform can be built and deployed in under six months.
Upsides
League's revenue grew 365% from 2020 to 2023, showing strong market demand.
Partnerships with companies like XO Health enhance League's market presence.
League's platform reduces total care costs by delivering member-centric experiences.
Funding
Total raised$166.43 M
Latest valuation$475.00 M
StageSERIES_C
SERIES C
1/31/2022$95
$475.00 MSERIES A
5/31/2016$25
$125.00 M$4
$20.00 M